nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An HER2 DNA vaccine with evolution-selected amino acid substitutions reveals a fundamental principle for cancer vaccine formulation in HER2 transgenic mice
|
Jones, Richard F. |
|
2019 |
68 |
7 |
p. 1143-1155 |
artikel |
2 |
An HER2 DNA vaccine with evolution-selected amino acid substitutions reveals a fundamental principle for cancer vaccine formulation in HER2 transgenic mice
|
Jones, Richard F. |
|
|
68 |
7 |
p. 1143-1155 |
artikel |
3 |
Checkpoint blockade immunotherapy enhances the frequency and effector function of murine tumor-infiltrating T cells but does not alter TCRβ diversity
|
Kuehm, Lindsey M. |
|
2019 |
68 |
7 |
p. 1095-1106 |
artikel |
4 |
Clinicopathological implications of TIM3+ tumor-infiltrating lymphocytes and the miR-455-5p/Galectin-9 axis in skull base chordoma patients
|
Zhou, Jinpeng |
|
2019 |
68 |
7 |
p. 1157-1169 |
artikel |
5 |
Combination of denosumab and immune checkpoint inhibition: experience in 29 patients with metastatic melanoma and bone metastases
|
Angela, Yenny |
|
2019 |
68 |
7 |
p. 1187-1194 |
artikel |
6 |
Comparison of IL-2 vs IL-7/IL-15 for the generation of NY-ESO-1-specific T cells
|
Gong, Wenjie |
|
2019 |
68 |
7 |
p. 1195-1209 |
artikel |
7 |
Cryptotanshinone has curative dual anti-proliferative and immunotherapeutic effects on mouse Lewis lung carcinoma
|
Liu, Shuo |
|
2019 |
68 |
7 |
p. 1059-1071 |
artikel |
8 |
Evaluation of the efficacy of immunotherapy for non-resectable mucosal melanoma
|
Moya-Plana, Antoine |
|
2019 |
68 |
7 |
p. 1171-1178 |
artikel |
9 |
First-in-human phase 1 dose-escalating trial of G305 in patients with advanced solid tumors expressing NY-ESO-1
|
Mahipal, Amit |
|
2019 |
68 |
7 |
p. 1211-1222 |
artikel |
10 |
Impact of combination immunochemotherapies on progression of 4NQO-induced murine oral squamous cell carcinoma
|
Ludwig, Sonja |
|
2019 |
68 |
7 |
p. 1133-1141 |
artikel |
11 |
Inhibition of murine hepatoma tumor growth by cryptotanshinone involves TLR7-dependent activation of macrophages and induction of adaptive antitumor immune defenses
|
Han, Zhen |
|
2019 |
68 |
7 |
p. 1073-1085 |
artikel |
12 |
Metabolic remodeling contributes towards an immune-suppressive phenotype in glioblastoma
|
Kesarwani, Pravin |
|
2019 |
68 |
7 |
p. 1107-1120 |
artikel |
13 |
Novel circulating tumor cell-based blood test for the assessment of PD-L1 protein expression in treatment-naïve, newly diagnosed patients with non-small cell lung cancer
|
Chen, Yen-Lin |
|
2019 |
68 |
7 |
p. 1087-1094 |
artikel |
14 |
Patterns of immune-cell infiltration in murine models of melanoma: roles of antigen and tissue site in creating inflamed tumors
|
Leick, Katie M. |
|
2019 |
68 |
7 |
p. 1121-1132 |
artikel |
15 |
Pembrolizumab as first-line treatment for metastatic uveal melanoma
|
Rossi, Ernesto |
|
2019 |
68 |
7 |
p. 1179-1185 |
artikel |
16 |
PLAC1: biology and potential application in cancer immunotherapy
|
Mahmoudian, Jafar |
|
2019 |
68 |
7 |
p. 1039-1058 |
artikel |